EGFR and lung adenocarcinoma: Mutations in the epidermal growth factor receptor (EGFR) kinase domain of lung adenocarcinoma have been viewed as the most reproducible predictive factor for susceptibility to first-generation EGFR tyrosine kinase inhibitors (TKIs) [7].